Esterase-activatable dimeric HDAC inhibitor nanotherapeutics for enhanced lymphoma epigenetic therapy.

Saved in:
Bibliographic Details
Title: Esterase-activatable dimeric HDAC inhibitor nanotherapeutics for enhanced lymphoma epigenetic therapy.
Authors: Li T; Department of Hematology, The Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang 310009, China; Department of Hematology, The First Affiliated Hospital of Ningbo University, 59 Liuting Road, Ningbo, Zhejiang 315010, China., Zhuang W; Department of Hematology, Lianyungang Second People's Hospital, Lianyungang, Jiangsu 222000, China., Fan S; Department of Hematology, The First Affiliated Hospital of Ningbo University, 59 Liuting Road, Ningbo, Zhejiang 315010, China., Yi P; Department of Research, Wuhan Kindstar Medical Laboratory Co. Ltd., 666 Gaoxin Avenue, Wuhan, Hubei 430060, China., Ouyang G; Department of Hematology, The First Affiliated Hospital of Ningbo University, 59 Liuting Road, Ningbo, Zhejiang 315010, China. Electronic address: fyyouyangguifang@nbu.edu.cn., Qian W; Department of Hematology, The Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang 310009, China. Electronic address: qianwb@zju.edu.cn.
Source: Colloids and surfaces. B, Biointerfaces [Colloids Surf B Biointerfaces] 2026 May; Vol. 261, pp. 115416. Date of Electronic Publication: 2026 Jan 08.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 9315133 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-4367 (Electronic) Linking ISSN: 09277765 NLM ISO Abbreviation: Colloids Surf B Biointerfaces Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41538977
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Esterase-activatable dimeric HDAC inhibitor nanotherapeutics for enhanced lymphoma epigenetic therapy.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Li+T%22">Li T</searchLink>; Department of Hematology, The Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang 310009, China; Department of Hematology, The First Affiliated Hospital of Ningbo University, 59 Liuting Road, Ningbo, Zhejiang 315010, China.<br /><searchLink fieldCode="AU" term="%22Zhuang+W%22">Zhuang W</searchLink>; Department of Hematology, Lianyungang Second People's Hospital, Lianyungang, Jiangsu 222000, China.<br /><searchLink fieldCode="AU" term="%22Fan+S%22">Fan S</searchLink>; Department of Hematology, The First Affiliated Hospital of Ningbo University, 59 Liuting Road, Ningbo, Zhejiang 315010, China.<br /><searchLink fieldCode="AU" term="%22Yi+P%22">Yi P</searchLink>; Department of Research, Wuhan Kindstar Medical Laboratory Co. Ltd., 666 Gaoxin Avenue, Wuhan, Hubei 430060, China.<br /><searchLink fieldCode="AU" term="%22Ouyang+G%22">Ouyang G</searchLink>; Department of Hematology, The First Affiliated Hospital of Ningbo University, 59 Liuting Road, Ningbo, Zhejiang 315010, China. Electronic address: fyyouyangguifang@nbu.edu.cn.<br /><searchLink fieldCode="AU" term="%22Qian+W%22">Qian W</searchLink>; Department of Hematology, The Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang 310009, China. Electronic address: qianwb@zju.edu.cn.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229315133%22">Colloids and surfaces. B, Biointerfaces</searchLink> [Colloids Surf B Biointerfaces] 2026 May; Vol. 261, pp. 115416. <i>Date of Electronic Publication: </i>2026 Jan 08.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>9315133 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1873-4367 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209277765%22">09277765 </searchLink><i>NLM ISO Abbreviation: </i>Colloids Surf B Biointerfaces <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41538977
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.colsurfb.2026.115416
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 115416
    Titles:
      – TitleFull: Esterase-activatable dimeric HDAC inhibitor nanotherapeutics for enhanced lymphoma epigenetic therapy.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Li T
      – PersonEntity:
          Name:
            NameFull: Zhuang W
      – PersonEntity:
          Name:
            NameFull: Fan S
      – PersonEntity:
          Name:
            NameFull: Yi P
      – PersonEntity:
          Name:
            NameFull: Ouyang G
      – PersonEntity:
          Name:
            NameFull: Qian W
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 05
              Text: 2026 May
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1873-4367
          Numbering:
            – Type: volume
              Value: 261
          Titles:
            – TitleFull: Colloids and surfaces. B, Biointerfaces
              Type: main
ResultId 1